Clinical Trials Directory

Trials / Completed

CompletedNCT00548301

Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-007)

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
—
Sponsor
Sirion Therapeutics, Inc. · Industry
Sex
All
Age
18 Years
Healthy volunteers
—

Summary

The purpose of this phase 3 study is to determine the safety and efficacy of cyclosporine in the treatment of dry eye syndrome.

Conditions

Interventions

TypeNameDescription
DRUGcyclosporine

Timeline

First posted
2007-10-23
Last updated
2011-07-01

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00548301. Inclusion in this directory is not an endorsement.

Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-007) (NCT00548301) · Clinical Trials Directory